Title: Predictive Genetic Testing & Consumer/Wellness Genomics Market Forecast to 2030: How it is going to Impact on Global Industry to Grow in Near Future
1Predictive Genetic Testing Consumer/Wellness
Genomics Market Size, Share and Industry Growth
Analysis Report 2023-2030
2Summary
Predictive Genetic Testing Consumer/Wellness
Genomics Market Report 2023-2030 SNS INSIDER
The predictive genetic testing and
consumer/wellness genomics market has experienced
substantial growth, with a valuation of USD 5.73
billion in 2022. Projections suggest that by
2030, the market will expand to USD 16.35
billion, reflecting a robust compound annual
growth rate (CAGR) of 14 during the forecast
period from 2023 to 2030. This growth can be
attributed to several factors, including
increasing consumer awareness and interest in
personalized healthcare, advancements in genetic
testing technologies, and the growing
availability of direct-to-consumer genetic
testing services. Predictive genetic testing and
consumer genomics offer individuals insights into
their genetic predispositions for various health
conditions, allowing them to make informed
decisions about their health and wellness. These
tests can provide information about disease risk,
pharmacogenomics, ancestry, and traits,
empowering individuals to take proactive steps to
manage their health and lifestyle. Additionally,
advancements in genomic sequencing technologies
and bioinformatics tools have led to the
development of more accurate and affordable
genetic tests, driving market growth.
Furthermore, the integration of genetic testing
into mainstream healthcare and wellness programs,
along with increasing adoption by healthcare
providers and insurance companies, is fueling
market expansion. However, challenges such as
privacy concerns, regulatory complexities, and
the need for improved genetic literacy among
consumers may impact market growth to some
extent. Nonetheless, the growing trend toward
personalized medicine and the increasing emphasis
on preventive healthcare are expected to drive
significant demand for predictive genetic testing
and consumer genomics services in the coming
years. This market presents lucrative
opportunities for companies operating in the
genetic testing space to innovate, expand their
product offerings, and cater to the evolving
needs of consumers seeking personalized health
insights.
3Market Growth Driver
Predictive Genetic Testing Consumer/Wellness
Genomics Market Report 2023-2030 SNS INSIDER
- The Predictive Genetic Testing and
Consumer/Wellness Genomics market is experiencing
notable growth driven by various factors. One of
the primary growth drivers is the increasing
consumer interest in understanding their genetic
makeup and potential health risks. Predictive
genetic testing allows individuals to assess
their predisposition to certain diseases and
conditions, empowering them to make informed
lifestyle choices and take proactive measures for
disease prevention. Moreover, advancements in
genetic sequencing technologies and
bioinformatics have led to the development of
direct-to-consumer (DTC) genetic testing kits,
making genetic testing more accessible and
affordable to the general public. This has fueled
the demand for consumer and wellness genomics
services, driving market growth globally. - Additionally, the growing prevalence of chronic
diseases and the shift towards personalized
medicine are further driving the adoption of
predictive genetic testing and consumer genomics
services.
4Market Opportunities
Predictive Genetic Testing Consumer/Wellness
Genomics Market Report 2023-2030 SNS INSIDER
Alongside growth drivers, the Predictive Genetic
Testing and Consumer/Wellness Genomics market
present various opportunities and challenges.
Opportunities lie in the development of
innovative genetic testing platforms and services
that offer actionable insights into health and
wellness. Integrating genetic testing with other
health data sources, such as electronic health
records (EHRs) and wearable devices, presents
opportunities for personalized health management
and disease prevention. Furthermore, partnerships
between genetic testing companies and healthcare
providers, as well as collaborations with
pharmaceutical companies for drug discovery and
clinical trials, offer avenues for market
expansion. However, challenges such as data
privacy and security concerns, regulatory
oversight, and the interpretation and
communication of genetic test results pose
significant hurdles. Ensuring the accuracy,
reliability, and clinical validity of genetic
tests, as well as addressing ethical and social
implications, are critical challenges that need
to be addressed to build trust and confidence in
predictive genetic testing and consumer genomics
services. Regional Overview In terms of regional
overview, the Predictive Genetic Testing and
Consumer/Wellness Genomics market exhibit diverse
dynamics across different regions. North America
dominates the market, driven by a strong presence
of genetic testing companies, favorable
regulatory environment, and high consumer
awareness and acceptance of genetic testing.
Europe represents another significant market,
characterized by increasing adoption of
personalized medicine and growing interest in
consumer genomics services. The Asia Pacific
region is witnessing rapid growth, fueled by
rising healthcare expenditure, increasing
consumer awareness of genetic testing, and
government initiatives to promote precision
medicine and genomics research in countries like
China, India, and Japan. Emerging markets in
Latin America and the Middle East Africa
also present
5Predictive Genetic Testing Consumer/Wellness
Genomics Market Report 2023-2030 SNS
INSIDER opportunities for market expansion,
although challenges such as regulatory barriers
and limited healthcare infrastructure may hinder
adoption. Overall, the Predictive Genetic Testing
and Consumer/Wellness Genomics market are poised
for continued growth globally, driven by ongoing
advancements in genetic science and increasing
demand for personalized health management
solutions.
Top Key Players
- Abbott Laboratories, Bio-Rad Laboratories Inc.,
Counsyl, Inc., Agilent Technologies, Bureau
Gravimétrique International, Genesis Genetics,
ARUP Laboratories, Hoffmann-La Roche Ltd.,
Illumina, Inc., Myriad Genetics, Inc., Thermo
Fisher Scientific - Market Segmentation
- By Test Type (Predictive Testing, Consumer
Genomics, Wellness Genomics) - By Application (Breast Ovarian Cancer,
Cardiovascular Screening, Diabetic Screening - Monitoring, Colon Cancer, Parkinsonism/Alzheimers
Disease, Urologic Screening/Prostate Cancer - Screening, Orthopedic Musculoskeletal)
- By Setting Type (Proteomic Testing, Metabolic
Testing, Genomic Testing)
6ABOUT US
Predictive Genetic Testing Consumer/Wellness
Genomics Market Report 2023-2030 SNS INSIDER
SNS Insider is a market
research company that delivers evidence-based
strategies for clients seeking growth.
Headquartered in India, we've developed to serve
our clients as they seek new growth possibilities
throughout the world. We have the worldwide reach
of a large research firm, but the agility and
individualized attention of a small boutique.
We're flexible and collaborative, with real ties
between our operations. What's the result?
Wherever
7- Predictive Genetic Testing Consumer/Wellness
Genomics Market Report 2023-2030 SNS INSIDER - you are in the world, you'll have access to our
global network of sector and methodology experts,
as well as the deep cultural awareness required
to ensure your project's success. - We offer our clients an integrated data and
research solution drawing on the companys three
core - competencies
- Syndicate
- Custom
- Consulting
- We manage the full research process from primary
data collecting to final report with our in-house
staff of Field Interviewers. Our researchers and
analysts work together to analyse all study data
and findings. On our custom-built data platform,
SNS has established a proprietary market size
model for every business sector. Our consultants
also help clients evaluate and apply research
findings and recommendations in their own
companies.